La Jolla Pharmaceutical (LJPC) Reports Q2 Loss of $0.70/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Price: $6.22 --0%
Financial Fact:
General and administrative: 3.47M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
General and administrative: 3.47M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q2 EPS of ($0.70), versus ($0.53) reported last year.
For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Ero Copper Corp. (ERO) Tops Q3 EPS by 14c
- Hillman Solutions (HLMN) Tops Q3 EPS by 1c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
